174 related articles for article (PubMed ID: 28499590)
1. MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
Xiang Y; Liao XH; Yu CX; Yao A; Qin H; Li JP; Hu P; Li H; Guo W; Gu CJ; Zhang TC
Exp Cell Res; 2017 Aug; 357(1):135-144. PubMed ID: 28499590
[TBL] [Abstract][Full Text] [Related]
2. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
3. STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells.
Liao XH; Xiang Y; Yu CX; Li JP; Li H; Nie Q; Hu P; Zhou J; Zhang TC
Oncotarget; 2017 Feb; 8(9):15763-15774. PubMed ID: 28178652
[TBL] [Abstract][Full Text] [Related]
4. MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
Xiang Y; Liao XH; Yao A; Qin H; Fan LJ; Li JP; Hu P; Li H; Guo W; Li JY; Gu CJ; Bao LY; Zhang TC
Exp Cell Res; 2017 Oct; 359(2):394-404. PubMed ID: 28822708
[TBL] [Abstract][Full Text] [Related]
5. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
6. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
7. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.
Hwang MS; Yu N; Stinson SY; Yue P; Newman RJ; Allan BB; Dornan D
PLoS One; 2013; 8(6):e66502. PubMed ID: 23776679
[TBL] [Abstract][Full Text] [Related]
8. miR520c blocks EMT progression of human breast cancer cells by repressing STAT3.
Wang N; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T; Li B
Oncol Rep; 2017 Mar; 37(3):1537-1544. PubMed ID: 28112380
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
10. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
11. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
[TBL] [Abstract][Full Text] [Related]
12. miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion.
Ye Q; Wang X; Yuan M; Cui S; Chen Y; Hu Z; Liu D; Han C; Li B; Chen D
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34339487
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
[TBL] [Abstract][Full Text] [Related]
14. MiR-17-5p and MKL-1 modulate stem cell characteristics of gastric cancer cells.
Dai ZT; Xiang Y; Duan YY; Wang J; Li JP; Zhang HM; Cheng C; Wang Q; Zhang TC; Liao XH
Int J Biol Sci; 2021; 17(9):2278-2293. PubMed ID: 34239355
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer.
Zhang H; Ge Z; Wang Z; Gao Y; Wang Y; Qu X
Aging (Albany NY); 2021 Mar; 13(6):8115-8126. PubMed ID: 33686957
[TBL] [Abstract][Full Text] [Related]
16. miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer.
Li H; Li HH; Chen Q; Wang YY; Fan CC; Duan YY; Huang Y; Zhang HM; Li JP; Zhang XY; Xiang Y; Gu CJ; Wang L; Liao XH; Zhang TC
Oncol Res; 2022 Jan; 28(9):885-897. PubMed ID: 34321149
[TBL] [Abstract][Full Text] [Related]
17. MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.
Luan QX; Zhang BG; Li XJ; Guo MY
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4257-4265. PubMed ID: 27831649
[TBL] [Abstract][Full Text] [Related]
18. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
19. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
[TBL] [Abstract][Full Text] [Related]
20. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway.
Zhang H; Cai K; Wang J; Wang X; Cheng K; Shi F; Jiang L; Zhang Y; Dou J
Stem Cells; 2014 Nov; 32(11):2858-68. PubMed ID: 25070049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
